logo
More San Diegans opting to take MTS over cars, new survey shows

More San Diegans opting to take MTS over cars, new survey shows

Yahoo18-04-2025

SAN DIEGO (FOX 5/KUSI) — San Diego Metropolitan Transit System ridership has still yet to fully rebound to pre-pandemic levels, but a recent survey conducted of its customers found they are becoming more satisfied with its services.
The survey, which was conducted by ETC Institute for the transit system last November, also found the transit system is far exceeding the national averages in every performance metric — from timeliness, convivence and reliability to cleanliness and safety.
On top of that, its results suggested the transit system's efforts to attract higher-income people who have a car or access to other options appear to be working, with greater shares of riders making $75,000 yearly or more saying they are choosing to use the system to get to their final destination than in years past.
'It's truly incredible,' Chris Tatham, CEO of the Kansas-based research firm who led the survey, said to the MTS Board of Directors during Thursday's monthly meeting. 'I do these presentations regularly. Very rarely do I see ratings as high as these.'
San Diego once had an extensive streetcar network. Can it make a comeback?
Of the roughly 4,000 randomly selected survey respondents, more than 80% expressed overall satisfaction with the transit system, with about five times as many people giving a better rating of the services than they did a year ago, compared to those whose opinion worsened.
The shifts came in tandem with high marks from respondents in areas like on-time performance, ease with finding out whether MTS buses or Trolleys are experiencing delays, level of convivence and efficiency, and presence of security throughout the network.
Each of these areas, which are ones MTS has made a concerted effort in recent years to improve upon, had more than 60% to 90% of surveyed customers respond positively to the transit system's performance, according to Tatham.
The metric where MTS performed the lowest — but was still above the national average — was in cleanliness at transit stops and in buses and trolleys. Only about 65% of bus riders and 53% of Trolley riders said the vehicles were clean, while 54% of respondents said stations were clean.
And it does not appear to be deterring riders. The survey found that far more bus and Trolley riders would recommend using MTS's services to friends or neighbors than those who would not or actively promote against it.
This has spilled into more people from higher-income levels choosing to take public transit compared to the last survey two years ago — something that Tatham noted he has observed nationally over the last few years.
In the study's demographic snapshot, roughly 23% of Trolley riders and 16% of bus riders reported annual income above $75,000.
Similar portions of MTS customers stated they were not dependent on transit to get around, meaning they have alternatives like driving alone or calling a rideshare service. About 28% of Trolley riders and 17% of bus riders reported having other options.
Of the people who said they were not reliant on MTS, many said they viewed the bus and Trolley 'just as convenient as walking or driving' or as a way to save money on car expenses like parking and gas.
Parking rate increases take effect in San Diego Bay waterfront
Work and school remained the top reasons why riders across the board were taking their respective trip when surveyed, but Tatham noted there has been an uptick in recent years of people using the system for leisure or to get to special events like sports games or concerts.
The survey is a promising sign for MTS as it sets out on another comprehensive analysis of the system operations and the effectiveness of its services.
The transit system's Board of Directors voted unanimously earlier this year to pursue the study, which would be the first since major capital projects like the Blue Line extension have come online, alongside one exploring a possible fare increase to avert a brewing budget crisis.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy

Yahoo

timean hour ago

  • Yahoo

SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy

VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Evri to hire thousands more couriers after deal with DHL
Evri to hire thousands more couriers after deal with DHL

Yahoo

time2 hours ago

  • Yahoo

Evri to hire thousands more couriers after deal with DHL

Evri is set to expand its courier network with a recruitment drive for 5,000 new couriers, as the company looks to compete in the business letter market. The Yorkshire-based parcel firm recently announced a collaboration with DHL's UK ecommerce division, creating one of the UK's largest delivery networks. The addition of these new roles will bring Evri's total number of self-employed couriers to 33,000. These positions will be available across the UK, with a focus on areas such as Plymouth, Bury, Hastings, Dover, and Scarborough. Approximately 1,000 of the new jobs will be permanent, while the remainder will be flexible roles designed to accommodate the increased demand during the summer and other peak delivery periods. Couriers who commit to working five or more days a week, including Saturday and Sunday, are also given the chance to opt in to its revamped 'Evri Plus' scheme, which includes paid holiday and automatic enrolment into a pension scheme. Evri, which was previously part of the Hermes parcel group, was bought by US private equity firm Apollo for around £2.7 billion last year. It announced plans last month to merge with rival DHL's UK ecommerce business to create a combined company set to deliver more than one billion parcels and one billion letters each year. The deal means Evri will enter the UK business letter market for the first time, bolstering its competition to Royal Mail. Evri has spent £32 million on improving its customer service offering and has seen an improvement in its ratings over recent years, but has said there is 'more to do' to improve with customers continuing to report delivery issues. Chief executive Martijn de Lange said: 'We know that service, reliability and quality are critical factors for our clients and consumers, and so by expanding our self-employed network further, we remain focused on delivering in each of those areas.' Couriers typically earn about £20.90 an hour on average, according to Evri. Sign in to access your portfolio

Evri to hire 5,000 more couriers after agreeing DHL tie-up
Evri to hire 5,000 more couriers after agreeing DHL tie-up

Yahoo

time2 hours ago

  • Yahoo

Evri to hire 5,000 more couriers after agreeing DHL tie-up

Evri is planning to hire 5,000 couriers in a fresh recruitment drive as the parcel giant takes on rivals after entering the business letter market. The Yorkshire-based firm recently announced it was joining forces with DHL's UK ecommerce arm to form one of the country's biggest delivery firms. It said the new roles would bring its total self-employed courier network to 33,000, its highest number. The roles will be available throughout the UK, with a focus on regions including Plymouth, Bury, Hastings, Dover and Scarborough. About 1,000 of the new jobs will be permanent, while the rest are set to be flexible positions to cater to the typically busy summer months and other peak periods for deliveries. Couriers who commit to working five or more days a week, including Saturday and Sunday, are also given the chance to opt in to its revamped 'Evri Plus' scheme, which includes paid holiday and automatic enrolment into a pension scheme. Evri, which was previously part of the Hermes parcel group, was bought by US private equity firm Apollo for around £2.7 billion last year. It announced plans last month to merge with rival DHL's UK ecommerce business to create a combined company set to deliver more than one billion parcels and one billion letters each year. The deal means Evri will enter the UK business letter market for the first time, bolstering its competition to Royal Mail. Evri has spent £32 million on improving its customer service offering and has seen an improvement in its ratings over recent years, but has said there is 'more to do' to improve with customers continuing to report delivery issues. Chief executive Martijn de Lange said: 'We know that service, reliability and quality are critical factors for our clients and consumers, and so by expanding our self-employed network further, we remain focused on delivering in each of those areas.' Couriers typically earn about £20.90 an hour on average, according to Evri.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store